COMMUNIQUÉS West-GlobeNewswire

Transactions in relation to share buyback program
12/02/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Chi-Med Highlights Preliminary Phase II Savolitinib / Imfinzi® Combination Data in Advanced Papillary Renal Cell Carcinoma at 2019 ASCO Genitourinary Cancers Symposium
12/02/2019
LONDON, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announced the availability of preliminary results from the Phase II CALYPSO study of the savolitinib / [...]
Almirall and Dermira Enter into Option and License Agreement for European Rights to Lebrikizumab
12/02/2019
- Almirall acquires option to license rights to develop and commercialize lebrikizumab for atopic dermatitis in Europe - Dermira to receive an option fee of $30 million - Lebrikizumab is an investigational anti-IL-13 [...]
Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) Split Dosing Regimen
12/02/2019
Media Release Copenhagen, Denmark, February 12, 2019 DARZALEX split dosing regimen approved by U.S. FDA Provides healthcare professionals with option to split first DARZALEX infusion over two consecutive days Approval [...]
Sanofi appoints Ameet Nathwani Chief Digital Officer
12/02/2019
Press Release Source: Sanofi (EURONEXT: SAN) (NASDAQ: SNY) Sanofi appoints Ameet Nathwani Chief Digital Officer Ameet Nathwani, M.D., will also continue to serve as Executive Vice-President, Chief Medical Officer Paris [...]
Sanofi nomme Ameet Nathwani au poste de Chief Digital Officer
12/02/2019
Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NASDAQ : SNY) Sanofi nomme Ameet Nathwani au poste de Chief Digital Officer Le Dr Ameet Nathwani continuera d'exercer les fonctions de Vice-Président Exécutif, [...]
Innate Pharma announces appointment of Laure-Hélène Mercier to the Executive Board
12/02/2019
INNATE PHARMA ANNOUNCES APPOINTMENT OF LAURE-HÉLÈNE MERCIER TO THE EXECUTIVE BOARD Appointments of Dr. Mondher Mahjoubi, Chief Executive Officer, and Dr. Yannis Morel, EVP Business Development and Portfolio Strategy, [...]
Innate Pharma annonce la nomination de Laure-Hélène Mercier au Directoire
12/02/2019
INNATE PHARMA ANNONCE LA NOMINATION DE LAURE-HÉLÈNE MERCIER AU DIRECTOIRE Les mandats de membres du Directoire Mondher Mahjoubi, Président du Directoire, et de Yannis Morel, Vice-président Exécutif, Stratégie Produits [...]
Veritas Pharma Announces the Resignation of CEO, Dr. Lui Franciosi
12/02/2019
VANCOUVER, British Columbia, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces the resignation of its President, CEO and Director, Dr [...]
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2019 Ended December 31, 2018 and Provides Conference Call Information
11/02/2019
Conference Call Scheduled for Tuesday, February 12 th at 11:30 AM EST NORTHVALE, N.J., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical [...]
Ascendis Pharma Initiates Global Phase 2 Trial for TransCon PTH in Adult Subjects with Hypoparathyroidism
11/02/2019
TransCon PTH is designed to provide parathyroid hormone in the physiologic range for 24 hours each day as a true replacement therapy for hypoparathyroidism COPENHAGEN, Denmark, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Ascendis [...]
Immunomedics Announces Oral Presentation at the 2019 Genitourinary Cancers Symposium
11/02/2019
MORRIS PLAINS, N.J., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
BioTelemetry, Inc. to Release Fourth Quarter 2018 Earnings Results on February 21, 2019
11/02/2019
MALVERN, Pa., Feb. 11, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2018 earnings on Thursday, February 21 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call [...]
Akorn to Report Fourth Quarter and Full Year 2018 Results
11/02/2019
LAKE FOREST, Ill., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release on Thursday, February 28, 2019 [...]
Cue Biopharma to Present Corporate Update at 2019 BIO CEO & Investor Conference
11/02/2019
CAMBRIDGE, Mass., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human [...]
Flexion Therapeutics Announces Publication of Data from Repeat Administration Trial of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) in Rheumatology and Therapy
11/02/2019
Results from Phase 3b clinical trial indicate that repeat administration of ZILRETTA for osteoarthritis (OA) knee pain was generally safe and well-tolerated X-ray data at baseline and Week 52 showed ZILRETTA had no [...]
Abeona Therapeutics Appoints João Siffert, M.D. Chief Executive Officer
11/02/2019
Former AveXis Director brings 30 years of experience to the Company NEW YORK and CLEVELAND, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company [...]
Xeris Pharmaceuticals Announces Proposed Public Offering of Shares of Common Stock
11/02/2019
CHICAGO, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable [...]
Pacific Biosciences Announces Fourth Quarter and Annual 2018 Financial Results
11/02/2019
MENLO PARK, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its fourth quarter and year ended December 31, 2018, as attached. During [...]

Pages